MDSO stock: buy or sell?
August 22nd, 2019
Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development.
Should I buy MDSO stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Medidata Solutions stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Medidata Solutions stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 9 ratings published for MDSO stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-6-12||William Blair||Outperform||Market Perform|
|2019-6-12||Piper Jaffray Companies||Overweight||Neutral|
|2019-6-12||JPMorgan Chase & Co.||Underweight||Neutral|
|2019-4-23||Wells Fargo & Co||Outperform||Market Perform|
|2019-1-4||Piper Jaffray Companies||n/a||Overweight|
|2019-1-2||Leerink Swann||n/a||Market Perform|
MDSO stock analysis
Shares of Medidata Solutions stayed constant a tight 0.12% and closed at $91.61.
Medidata Solutions closed yesterday at $91.61 and stayed stable a tight 0.12%. Since SMA100d and SMA200d crossed up on May, MDSO price slid a -1.30%. On April MDSO price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. On April, MDSO hit a new all time high, pushing higher than on April tops. Check different trading setups that use ATHs as triggers.
Medidata Solutions shares stayed steady 0.12% this week, ending at $91.61. With this, it's been 5 climbing weeks in a row, soaring a 0.95%.
Far behind is the all-time high Medidata Solutions hit late April but price is just -7.09% below that top. Since SMA20w and SMA40w crossed up early May, MDSO price slid a -2.51%. Early April MDSO price bounced up over the SMA of 40 weeks that acted as support stopping new slides.
MDSO stock price history
MDSO IPO was on June 25th, 2009 at $9.00 per share1. Since then, MDSO stock grew a 917.90%, with a yearly average of 91.80%. If you had invested $1,000 in MDSO stock in 2009, it would worth $9,179.00 today.
1: Adjusted price after possible price splits or reverse-splits.
MDSO stock historical price chart
MDSO stock reached all-time highs on April with a price of $98.60.
MDSO stock price target is $87.60Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' MDSO stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 2 price forecasts for MDSO stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-6-13||SunTrust Banks||Raises Target||$85.00||$92.25||8.5%|
|2019-1-4||Piper Jaffray Companies||Lowers Target||n/a||$83.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareMedidata Solutions reported exceptional results for 2018-Q4 on February. Medidata Solutions boosted Earnings per Share (EPS) by 62.50%, beating analysts estimates of $0.16. Medidata Solutions posted $0.26.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Medidata Solutions annual sales rocketed an amazing 16.81% to $635.70 M dollars from $544.21 marked in 2017. When comparing 2018 vs 2017, in contrast, profit margin (that is, the net income divided by revenues) remained constant a -0.57% to 8.17%.
|2013||$277 M||-||$17 M6.0%||-|
|2014||$335 M||21.03%||$6.09 M1.8%||-63.43%|
|2015||$393 M||17.14%||$13 M3.4%||116.14%|
|2016||$463 M||18.06%||$29 M6.3%||120.12%|
|2017||$544 M||17.44%||$48 M8.7%||64.15%|
|2018||$636 M||16.81%||$52 M8.2%||9.13%|
Quarterly financial resultsMedidata Solutions posted $167.19 M in sales for 2018-Q4, a 2.31% improvement compared to previous quarter. Reported quarter income marked $14.32 million with a profit margin of 8.56%. Profit margin stepped up a 2.02% compared to previous quarter when profit margin was 6.54%. When comparing sales to same quarter last year, Medidata Solutions sales marked an extraordinary gain and skyrocketed a 16.98%. Looking back to recent quarterly results, Medidata Solutions posted 6 negative quarters in a row.
|2017-Q2||$137 M||-||$8 M6.0%||-|
|2017-Q3||$140 M||1.94%||$13 M9.2%||55.64%|
|2017-Q4||$143 M||2.02%||$14 M9.7%||7.60%|
|2018-Q1||$149 M||4.40%||$10 M6.9%||-25.27%|
|2018-Q2||$156 M||4.50%||$17 M10.6%||60.67%|
|2018-Q3||$163 M||4.81%||$11 M6.5%||-35.57%|
|2018-Q4||$167 M||2.31%||$14 M8.6%||33.97%|
|2019-Q1||$174 M||3.78%||$11 M6.4%||-22.17%|
Medidata Solutions ownershipWhen you are planning to invest in shares of a stock, it's always worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medidata Solutions, 3.80% of all outstanding shares are owned by its staff.
Bearish positions for MDSO stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Medidata Solutions:
|Market cap||$5.7 B||$148.5 B||$181.9 B||$650.9 M|
|Total shares||62.3 M||1,760.0 M||3,420.0 M||17.5 M|
|Float shares||57.9 M||1,750.0 M||2,190.0 M||12.2 M|
|- Institutional holdings (%)||106.9%||76.5%||58.6%||43.0%|
|- Insider holdings (%)||3.8%||0.7%||33.4%||30.8%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%|
|Thursday, August 22nd, 2019|
|Day range||$91.51 - $91.65|
|Average true range||$0.19|
|50d mov avg||$91.08|
|100d mov avg||$89.17|
|200d mov avg||$80.48|
Medidata Solutions performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Medidata Solutions, the comparison is made against , Oracle and Simulations Plus.